找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Somatostatin; Coimbatore B. Srikant Textbook 2004 Springer Science+Business Media New York 2004 apoptosis.biology.cancer.cell.genetics.hor

[复制链接]
楼主: expenditure
发表于 2025-4-1 05:16:33 | 显示全部楼层
Somatostatin Receptor Targeted-Radio-Ablation of Tumors new treatment modality for patients bearing sst.-positive tumors. In PRRT the goal is to deliver an effective radiation dose to the tumor without causing undesired effects in healthy tissues. Improvements in the success of radionuclide therapy also depend on the optimization of radiation doses to t
发表于 2025-4-1 10:01:44 | 显示全部楼层
Textbook 2004ons of somatostatin and its receptors stimulated intense scientific and clinical interest, and fostered extensive research into all aspects of its biology including regulation of its gene expression, processing of its precursor, biological and cellular actions relating to regulation cell secretion,
发表于 2025-4-1 12:12:13 | 显示全部楼层
Somatostatin Analogs in the Treatment of Pituitary Tumorsprovement of cardiomyopathy, sleep apnea and arthropathy has been reported during treatment with these somatostatin analogs. LAN displayed beneficial effects also in TSH-secreting adenomas, while the results of treatment with these peptides in patients with clinically nonfunctioning adenomas are still rather limited and controversial.
发表于 2025-4-1 17:56:26 | 显示全部楼层
Expression of Somatostatin Receptors in Human Tissues in Health and Diseasenificant growth advantage to these tumors (17). One of the main challenges for the future will be to unravel the various physiological and pathophysiological roles of somatostatin mediated by SSTR subtypes, and identify potential therapeutical indications for the newly developed subtypeselective somatostatin analogs (27–29).
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 19:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表